MicroTech Medical-B (02235) said its next-generation split-type continuous glucose monitoring system, AiDEX G9, has received marketing approval from China's National Medical Products Administration, according to ETNet.

The company said AiDEX G9 represents a technical architecture change from the first-generation split-type product and has been upgraded in size, portability and wearing comfort to give diabetes patients a lighter and more comfortable blood glucose management experience.